{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:01:08Z","timestamp":1790614868479,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jocd.2012.11.012","type":"journal-article","created":{"date-parts":[[2012,12,23]],"date-time":"2012-12-23T14:45:18Z","timestamp":1356273918000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Secondary and Tertiary Hyperparathyroidism"],"prefix":"10.1016","volume":"16","author":[{"given":"Sophie A.","family":"Jamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2012.11.012_bib1","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","article-title":"RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate","volume":"273","author":"Moallem","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocd.2012.11.012_bib2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2012.11.012_bib3","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI105877","article-title":"Control of phosphate excretion in uremic man","volume":"47","author":"Slatopolsky","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2012.11.012_bib4","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2012.11.012_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocd.2012.11.012_bib6","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in\u00a0vivo","volume":"86","author":"Naveh-Many","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2012.11.012_bib7","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jocd.2012.11.012_bib8","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V661530","article-title":"A cloned Ca(2+)-sensing receptor: a mediator of direct effects of extracellular Ca2+ on renal function?","volume":"6","author":"Brown","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jocd.2012.11.012_bib9","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1210\/jcem.86.11.7978","article-title":"Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia","volume":"86","author":"Sato","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.012_bib10","first-page":"1514","article-title":"Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets","volume":"75","author":"Rivkees","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2012.11.012_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2265.1995.tb01863.x","article-title":"Autonomous hyperparathyroidism in X-linked hypophosphataemia","volume":"42","author":"Knudtzon","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jocd.2012.11.012_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2265.2003.01685.x","article-title":"Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets","volume":"58","author":"Makitie","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jocd.2012.11.012_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.11.012_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03343720","article-title":"Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia","volume":"23","author":"Huang","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2012.11.012_bib15","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1111\/j.1399-0012.2011.01515.x","article-title":"Intact parathyroid hormone levels in renal transplant patients with normal transplant function","volume":"25","author":"Bleskestad","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jocd.2012.11.012_bib16","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hed.20628","article-title":"Clinical and operative management of persistent hyperparathyroidism after renal transplantation: a single-center experience","volume":"29","author":"Gilat","year":"2007","journal-title":"Head Neck"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2012.11.012_bib17","first-page":"N2","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2012.11.012_bib18","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jocd.2012.11.012_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semnephrol.2009.01.009","article-title":"Bone disease in kidney transplant patients","volume":"29","author":"Huang","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jocd.2012.11.012_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1440-1797.2009.01156.x","article-title":"Review article: Managing bone complications after kidney transplantation","volume":"14","author":"Mainra","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jocd.2012.11.012_bib21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00268-007-9187-z","article-title":"Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters!","volume":"31","author":"Schlosser","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.jocd.2012.11.012_bib22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/000313481207800544","article-title":"Total parathyroidectomy versus subtotal parathyroidectomy in the treatment of tertiary hyperparathyroidism","volume":"78","author":"Hsieh","year":"2012","journal-title":"Am Surg"},{"key":"10.1016\/j.jocd.2012.11.012_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11255-011-0069-9","article-title":"Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up","volume":"44","author":"Sadideen","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jocd.2012.11.012_bib24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","article-title":"Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism","volume":"20","author":"Serra","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocd.2012.11.012_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ndt\/gfl560","article-title":"Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients","volume":"22","author":"Serra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocd.2012.11.012_bib26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocd.2012.11.012_bib27","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/ndt\/gfm270","article-title":"Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism","volume":"22","author":"Kruse","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jocd.2012.11.012_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11926-012-0243-9","article-title":"Bone and kidney disease: diagnostic and therapeutic implications","volume":"14","author":"Jamal","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jocd.2012.11.012_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1525-139X.2012.01096.x","article-title":"Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease","volume":"25","author":"West","year":"2012","journal-title":"Semin Dial"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695012002417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:38:24Z","timestamp":1761082704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695012002417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1094695012002417"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2012.11.012","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary and Tertiary Hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2012.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}